Celgene Q3 Beats, Drops, Rolls Published: Oct 21, 2004 Predictably, Celgene (CELG) beat its Q3 earnings projections. Just as predictably, the stock sold off in the first hours of trading, dropping $4.02 (6.4%) to $58.36 by mid-day. Related links ChinaBio Today [Sub. Required] This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news
